STIGALL L. JEREMY (GM, Biologics & Drug Delivery) received a stock award from CLEARPOINT NEURO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2026ACC: 0001193125-26-294477
Officer· GM, Biologics & Drug Delivery
Since May 2022
+1.78K
Net shares
Net buyer
$21.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.78K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.78K
Price / share
$11.93
Trade value
$21.25K
% of position
1.6%
6/30/2026
108.48K→110.26K
Total
Net shares
+1.78K
Net value
$21.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | A · Award | +1.78K | $11.93 | $21.25K | 1.6% | 108.48K | 110.26K |
| Total | +1.78K | $21.25K | ||||||
Derivative Transactions0
No derivative transactions reported